Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-18 4:17 pm Sale | 2025-11-11 | 13G | SEALED AIR CORP SEE | Integrated Core Strategies (US) LLC | 5,397,940 3.700% | -2,146,412 (-28.45%) | Filing History |
| 2025-11-13 4:29 pm Sale | 2025-09-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Integrated Core Strategies (US) LLC | 1,138,484 4.100% | -243,789 (-17.64%) | Filing History |
| 2025-11-13 4:28 pm Sale | 2025-09-30 | 13G | ANI PHARMACEUTICALS INC ANIP | Integrated Core Strategies (US) LLC | 65,245 0.300% | -1,051,415 (-94.16%) | Filing History |
| 2025-11-12 4:17 pm Purchase | 2025-11-05 | 13G | ZEPP HEALTH CORP ADR ZEPP | Integrated Core Strategies (US) LLC | 6,634,592 5.800% | 6,634,592 (New Position) | Filing History |
| 2025-11-12 4:10 pm Sale | 2025-09-30 | 13G | MYRIAD GENETICS INC MYGN | Integrated Core Strategies (US) LLC | 4,748,327 5.100% | -176,387 (-3.58%) | Filing History |
| 2025-11-10 4:50 pm Purchase | 2025-11-04 | 13G | AMN HEALTHCARE SERVICES AMN | Integrated Core Strategies (US) LLC | 2,446,024 6.400% | 2,446,024 (New Position) | Filing History |
| 2025-11-07 4:42 pm Sale | 2025-09-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Integrated Core Strategies (US) LLC | 2,313,642 3.200% | -522,650 (-18.43%) | Filing History |
| 2025-11-07 4:14 pm Purchase | 2025-11-03 | 13G | SEALED AIR CORP SEE | Integrated Core Strategies (US) LLC | 7,544,352 5.100% | 7,544,352 (New Position) | Filing History |
| 2025-11-06 4:19 pm Purchase | 2025-09-30 | 13G | LIVANOVA PLC SHS LIVN | Integrated Core Strategies (US) LLC | 2,970,114 5.400% | 905,091 (+43.83%) | Filing History |
| 2025-11-05 4:24 pm Purchase | 2025-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Integrated Core Strategies (US) LLC | 313,712 6.900% | 80,096 (+34.29%) | Filing History |
| 2025-11-04 4:22 pm Purchase | 2025-10-29 | 13G | ORTHOPEDIATRICS CORP COM KIDS | Integrated Core Strategies (US) LLC | 1,390,656 5.500% | 1,390,656 (New Position) | Filing History |
| 2025-10-30 4:19 pm Sale | 2025-09-30 | 13G | CUMBERLAND PHARMACEUTICALS INC CPIX | Integrated Core Strategies (US) LLC | 598,634 4.000% | -211,263 (-26.09%) | Filing History |
| 2025-10-30 4:19 pm Sale | 2025-09-30 | 13G | AFFILIATED MANAGERS GROUP INC AMG | Integrated Core Strategies (US) LLC | 1,017,113 3.600% | -488,991 (-32.47%) | Filing History |
| 2025-10-29 4:07 pm Purchase | 2025-10-23 | 13G | HARVARD AVE ACQ CORP USD UNITS HAVAU | Integrated Core Strategies (US) LLC | 950,000 6.400% | 950,000 (New Position) | Filing History |
| 2025-10-28 4:10 pm Sale | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Integrated Core Strategies (US) LLC | 570,994 3.000% | -361,869 (-38.79%) | Filing History |
| 2025-10-27 4:32 pm Purchase | 2025-10-20 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 1,901,585 9.000% | 1,901,585 (New Position) | Filing History |
| 2025-10-23 4:18 pm Purchase | 2025-10-16 | 13G | FIRST HORIZON CORPORATION FHN | Integrated Core Strategies (US) LLC | 25,405,699 5.000% | 25,405,699 (New Position) | Filing History |
| 2025-10-20 4:23 pm Sale | 2025-10-14 | 13G | ASTRIA THERAPEUTICS INC ATXS | Integrated Core Strategies (US) LLC | 222,101 0.400% | -2,715,702 (-92.44%) | Filing History |
| 2025-10-09 4:06 pm Sale | 2025-10-07 | 13G | COMERICA INC CMA | Integrated Core Strategies (US) LLC | 4,608,328 3.600% | -4,074,815 (-46.93%) | Filing History |
| 2025-10-01 4:15 pm Purchase | 2025-09-29 | 13G | BIOXCEL THERAPEUTICS INC N BTAI | Integrated Core Strategies (US) LLC | 1,028,053 5.200% | 1,028,053 (New Position) | Filing History |